A detailed history of Dimensional Fund Advisors LP transactions in Biogen Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,114,340 shares of BIIB stock, worth $168 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,114,340
Previous 1,110,112 0.38%
Holding current value
$168 Million
Previous $257 Million 16.07%
% of portfolio
0.05%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$189.07 - $236.8 $799,387 - $1 Million
4,228 Added 0.38%
1,114,340 $216 Million
Q2 2024

Aug 09, 2024

SELL
$190.52 - $236.72 $40.2 Million - $49.9 Million
-210,874 Reduced 15.96%
1,110,112 $257 Million
Q1 2024

May 10, 2024

SELL
$212.02 - $267.71 $22 Million - $27.8 Million
-103,673 Reduced 7.28%
1,320,986 $285 Million
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $9.67 Million - $11.6 Million
43,444 Added 3.15%
1,424,659 $369 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $8.99 Million - $10.1 Million
35,473 Added 2.64%
1,381,215 $355 Million
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $19.5 Million - $22.5 Million
-70,779 Reduced 5.0%
1,345,742 $383 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $18.8 Million - $21.4 Million
73,289 Added 5.46%
1,416,521 $394 Million
Q4 2022

Feb 09, 2023

SELL
$252.44 - $306.72 $5 Million - $6.08 Million
-19,821 Reduced 1.45%
1,343,232 $372 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $21.9 Million - $30.2 Million
112,599 Added 9.0%
1,363,053 $364 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $2.89 Million - $3.44 Million
15,431 Added 1.25%
1,250,454 $255 Million
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $8.29 Million - $10.4 Million
42,773 Added 3.59%
1,235,023 $260 Million
Q4 2021

Feb 09, 2022

BUY
$223.92 - $287.77 $13.9 Million - $17.9 Million
62,060 Added 5.49%
1,192,250 $286 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $16.3 Million - $21.2 Million
-57,498 Reduced 4.84%
1,130,190 $320 Million
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $19.4 Million - $31.1 Million
75,020 Added 6.74%
1,187,688 $411 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $943,374 - $1.11 Million
-3,883 Reduced 0.35%
1,112,668 $311 Million
Q4 2020

Feb 25, 2021

BUY
$236.26 - $355.63 $264 Million - $397 Million
1,116,551 New
1,116,551 $273 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.